Sarcopenia index as a predictor of clinical outcomes in older patients undergoing transcatheter aortic valve replacement.

Francisco José Romeo Juan Guido Chiabrando Ignacio Miguel SeropianJuan Valle RaleighHoracio Medina de ChazalCristian Maximiliano GarmendiaMaximiliano SmietnianskyMariela CalCarla Romina AgatielloDaniel Horacio Berrocal

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)

Sarcopenia Index, surrogate for the degree of skeletal muscle mass (SMM), could be used as a predictor of adverse outcomes in patients undergoing TAVR.

Keyphrases

transcatheter aortic valve replacement
skeletal muscle
patients undergoing
aortic stenosis
aortic valve
community dwelling
insulin resistance
physical activity
heart failure
middle aged
ejection fraction
coronary artery disease
metabolic syndrome